Trial comparing three drugs for status epilepticus

Related posts:

1. New study aims to optimize brain development in babies with congenital heart disease An upcoming clinical trial at Children's National Hospital will harness cardiopulmonary bypass as a delivery mechanism for a novel intervention designed to stimulate brain growth and repair in children who undergo cardiac surgery for congenital heart disease....
2. Comparative study finds three anti-seizure drugs to be equally safe and effective A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective....
3. The Strategy of mTORC1 Inhibition Fails a Phase III Trial The worst possible outcome when developing a clinical therapy is not an early failure. It is a late failure, in the final and most expensive phase III clinical trial, in which the therapy interacts with a sizable patient population, and after a great deal of time and funding have been devoted to the program. This result is far more likely for therapies based on mechanisms that have smaller rather than larger effect sizes, and where that smaller effect size varies from individual to individual for reasons that are not well understood - something that describes all too much of...
4. A Mediterranean diet and exercise to reverse dementia? This trial will give the answer Experts say a 'dementia tsunami' is coming. But a ground-breaking study of 6,000 Australians is assessing whether diet and exercise can dramatically reduce a person's risk of developing the condition — and potentially reverse some symptoms. ...
5. Clinical trial: Oral drug improves exercise capacity in teens with congenital heart defects The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects....